Skip to content

Endoscopic Optimized treatment of early and middle cervical cancer patients

Early diagnosis and treatment system for cervical cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONR-17011651
Enrollment
Unknown
Registered
2017-06-13
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Conventional surgery group:Conventional Surgery
Optimized surgery group:Optimized Surgery

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as cervical squamous cell carcinoma or adenocarcinoma by biopsy, mass size = 4cm; 2. Cancer tissue differentiation can be G1 / G2 / G3; 3. Patient without the need for fertility; 4. CT / MRI / PET-CT examination showed no distant metastasis, with or without pelvic lymph nodes (= 5mm); 5. Completing surgery within 4 weeks; 6. No preoperative neoadjuvant chemotherapy; 7. Patients signs the written informed consent; 8. Patients can receive chemotherapy and regular follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with fertility requirements; 2. Patients can not receive surgical procedures; 3. Patients with serious complications of internal and external surgery can not tolerate surgery; 4. Preoperative prompted patients with distant metastases or distant lymph node metastasis; 5. Patients with iodine allergy.

Design outcomes

Primary

MeasureTime frame
Cervical cancer Ia1-IIa1 cells;

Countries

China

Contacts

Public ContactXiaowen Tong

Shanghai Tongji Hospital

xiaowen_tong@yahoo.com+86 13601626510

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026